Cleveland Clinic's 20th Annual ASH Review
B

2019 ASH Review on MCL: Can Anti-CD19 CAR-T Cell Therapy Be Used for Mantle Cell Lymphoma Patients After BTK Inhibitor Failure?

By Cleveland Clinic's 20th Annual ASH Review FEATURING Brian Hill
By Cleveland Clinic's 20th Annual ASH Review FEATURING Brian Hill
157 views
April 14, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Related Content

AUTOPLAY
10:27
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Rates of CRS and ICANS From CIBMTR Data o…

Feat. J. DiPersio
40:21
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Overview of Hematopoietic Cell Transplantation

Feat. R. Salit
31:12
UChicago Medicine

Practice-Changing Abstracts in NHL and HL From ASH 2023

Feat. S. Smith
04:34
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "Highlights and Key Takeaways in MCL"

Feat. P. Jain
26:58
Total Health

Update on Cellular Therapy in Lymphoma

Feat. B. Randolph
16:05
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: What Is High Risk MCL and How Should We Treat It

Feat. A. Kumar
06:43
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "The Best of MCL - Highlights & Key Takea…

Feat. V. Yazbeck
07:22
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Hypertension in Pts With CLL and Other Heme…

Feat. A. Ferrajoli
05:24
Chan Cheah

Efficacy of Pirtobrutinib in Covalent BTKi Pre-Treated R/R MCL: Addi…

05:28
GRACE

3L Treatment for Mantle Cell Lymphoma

Feat. T. Phillips
12:54
The University of Alabama at Birmingham School of Medicine

Tips and Tricks in Treatment of MCL: Choice of Regimens and Dosing C…

Feat. M. Narkhede
06:18
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Pirtobrutinib in cBTKi Pre-Treated MCL - …

Feat. N. Shah
04:13
GRACE

The TRIANGLE Study: Ibrutinib Maintenance for MCL

Feat. T. Phillips
44:19
University of Colorado Division of Hematology

Mantle Cell Lymphoma: Challenges & Prospects

Feat. J. Jasem
37:44
University of Colorado Division of Hematology

Summary and Practice Impacts of Recent Updates in B-Cell Lymphomas

Feat. M. Kamdar
08:19
ASH 2022 Conference Coverage

ASH 2022 Results From the Phase 1/2 BRUIN Study: Safety & Tolera…

Feat. N. Shah
03:26
PrecisCa

The BRUIN Study: Pirtobrutinib in Mantle Cell Lymphoma

Feat. M. Kamdar
18:18
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: Emerging BCL2 Inhibitors

Feat. M. Ann Anderson
03:42
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "BELLWAVE-003 - A Phase 2 Dose Escalation,…

Feat. G. Perini
36:10
University of Colorado Division of Hematology

2023 Denver ASH Review: Updates in CLL and Lymphoma

Feat. A. Major